Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.

Biotechnology

Abcuro

Abcuro's headquarters in Newton, MA, United States

Alex Martin

H. Jeffrey Wilkins, MD

Courtney Cupples

Karen Tubridy

Rajeev Shah

Steven A Greenberg

Jay Knowles

Jason P. Hafler

Dietmar Berger

Yajun Xu

Jonah Cashdan

Mark Pruzanski

Mike Dybbs

Tomer Kariv

Ming Fang

The Management and Directors team at Abcuro oversees strategic decision-making, operations, program management, analytical development, and human resources. This team ensures that the company's clinical advancements, such as the ABC008 anti-KLRG1 antibody, align with overall business objectives and regulatory standards to effectively treat autoimmune and cancer indications.

Management and Directors

The Clinical Operations Team at Abcuro is responsible for overseeing the execution and management of clinical trials, ensuring regulatory compliance, and coordinating cross-functional efforts to advance ABC008 through its clinical studies. This team manages all aspects of clinical trial operations, including site selection, patient recruitment, data collection, and trial monitoring to ensure the trials are conducted efficiently and effectively, thereby supporting the development of new therapies for autoimmune and cancer indications.

Clinical Operations Team

The Finance and Accounting Team at Abcuro oversees all financial operations and ensures regulatory compliance. This involves managing budgets, preparing financial statements, conducting financial analyses, and providing strategic financial planning to support the company's clinical development programs. The team is essential in maintaining financial health, assisting in funding rounds, and delivering accurate financial reports to stakeholders.

Finance and Accounting Team

The Observers team at Abcuro plays a critical role in monitoring and documenting the progress of clinical studies for ABC008, ensuring data accuracy and regulatory compliance. They meticulously record patient responses, treatment outcomes, and any adverse effects, providing essential data to guide the development of the anti-KLRG1 antibody therapy for inclusion body myositis (IBM).

Observers

The Supply Chain and Manufacturing team at Abcuro is responsible for overseeing the production and distribution of ABC008 and other therapeutic products. This team ensures the efficient and compliant manufacturing of clinical-grade compounds, manages logistics and supply chain operations, and coordinates the end-to-end process from raw material sourcing to product delivery. They play a crucial role in advancing Abcuro's clinical trials by ensuring that high-quality treatment materials are available as needed.

Supply Chain and Manufacturing

This department focuses on the development and optimization of analytical methods and processes for drug formulation and quality assurance.

Abcuro

Org chart

Board & advisors

Teams

Management and Directors

Clinical Operations Team

Finance and Accounting Team

Observers

Supply Chain and Manufacturing

Analytical Development

Offices

Abcuro

Org chart

Board & advisors

Teams

Management and Directors

Clinical Operations Team

Finance and Accounting Team

Observers

Supply Chain and Manufacturing

Analytical Development

Offices

Related companies